- Home
- All Stock List
- NSE
- Healthcare Global Enterprises Ltd Share Price
Healthcare Global Enterprises Ltd Share Price – NSE / BSE
Healthcare, Small Cap
-
85
Like
-
Share
-
Feedback
542.10
14.40 (2.73%)
-
Outperforms Index
60.46%
Return (1Y)
Beaten Nifty 50 by 55.11%
-
More Volatile
2.02%
Standard Deviation (1Y)
Higher than Nifty 50 by 1.14%
-
Consistent Performer
11/12
Months
beaten Nifty 50
-
AxisDirect View
No View
568
331
News & Announcements
-
HCG shares up as KKR set to steer the ship
36 days ago
The agreement, which involves a transaction with CVC, a global private markets manager, will see KKR acquire up to 54% of HCG’s equity from CVC Asia V at a price of Rs 445 per share.
In accordance with the Securities and Exchange Board of India (SEBI) Takeover Regulations, KKR will also conduct an open offer to purchase additional equity shares from public shareholders. Upon completion of the transaction, KKR's total equity stake in HCG is expected to range between 54% and 77%.
Dr. BS Ajaikumar, the founder of HCG, will transition to the role of non-executive chairman, where he will focus on driving clinical, academic, and research and development excellence within the organization.
The transaction is expected to close by the third quarter of 2025, subject to customary closing conditions and regulatory approvals.
Separately, KKR has initiated an open offer to acquire up to 26% of HCG’s expanded voting share capital, offering to purchase 3,70,90,327 equity shares at Rs 504.41 per share, for a total consideration of Rs 1870,87,31,842.07.
Founded in 1989, HCG is one of India’s largest oncology hospital chains. HCG operates 25 medical care centers across 19 cities with best-in-class infrastructure including 2,500 beds, nearly 100 operating theaters and 40 linear accelerator machines (LINACs).
Powered by Capital Market - Live News
-
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
46 days ago
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
14 - Feb - 2025 12:00 | 46 days ago
Net profit of Healthcare Global Enterprises rose 22.46% to Rs 6.98 crore in the quarter ended December 2024 as against Rs 5.70 crore during the previous quarter ended December 2023. Sales rose 18.89% to Rs 557.55 crore in the quarter ended December 2024 as against Rs 468.95 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 557.55 468.95 19 OPM % 15.85 16.76 - PBDT 53.22 55.22 -4 PBT -3.30 11.06 PL NP 6.98 5.70 22 Powered by Capital Market - Live News
-
Healthcare Global Enterprises has revised the meeting of the Board of Directors which was scheduled to be held on 13 February 2025. The meeting will now be held on 14 February 2025.
Powered by Capital Market - Live News
-
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
46 days ago
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
14 - Feb - 2025 12:00 | 46 days ago
Net profit of Healthcare Global Enterprises rose 22.46% to Rs 6.98 crore in the quarter ended December 2024 as against Rs 5.70 crore during the previous quarter ended December 2023. Sales rose 18.89% to Rs 557.55 crore in the quarter ended December 2024 as against Rs 468.95 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 557.55 468.95 19 OPM % 15.85 16.76 - PBDT 53.22 55.22 -4 PBT -3.30 11.06 PL NP 6.98 5.70 22 Powered by Capital Market - Live News
-
Healthcare Global Enterprises has revised the meeting of the Board of Directors which was scheduled to be held on 13 February 2025. The meeting will now be held on 14 February 2025.
Powered by Capital Market - Live News
-
-
HCG shares up as KKR set to steer the ship
36 days ago
The agreement, which involves a transaction with CVC, a global private markets manager, will see KKR acquire up to 54% of HCG’s equity from CVC Asia V at a price of Rs 445 per share.
In accordance with the Securities and Exchange Board of India (SEBI) Takeover Regulations, KKR will also conduct an open offer to purchase additional equity shares from public shareholders. Upon completion of the transaction, KKR's total equity stake in HCG is expected to range between 54% and 77%.
Dr. BS Ajaikumar, the founder of HCG, will transition to the role of non-executive chairman, where he will focus on driving clinical, academic, and research and development excellence within the organization.
The transaction is expected to close by the third quarter of 2025, subject to customary closing conditions and regulatory approvals.
Separately, KKR has initiated an open offer to acquire up to 26% of HCG’s expanded voting share capital, offering to purchase 3,70,90,327 equity shares at Rs 504.41 per share, for a total consideration of Rs 1870,87,31,842.07.
Founded in 1989, HCG is one of India’s largest oncology hospital chains. HCG operates 25 medical care centers across 19 cities with best-in-class infrastructure including 2,500 beds, nearly 100 operating theaters and 40 linear accelerator machines (LINACs).
Powered by Capital Market - Live News
-
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
46 days ago
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
14 - Feb - 2025 12:00 | 46 days ago
Net profit of Healthcare Global Enterprises rose 22.46% to Rs 6.98 crore in the quarter ended December 2024 as against Rs 5.70 crore during the previous quarter ended December 2023. Sales rose 18.89% to Rs 557.55 crore in the quarter ended December 2024 as against Rs 468.95 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 557.55 468.95 19 OPM % 15.85 16.76 - PBDT 53.22 55.22 -4 PBT -3.30 11.06 PL NP 6.98 5.70 22 Powered by Capital Market - Live News
-
Healthcare Global Enterprises has revised the meeting of the Board of Directors which was scheduled to be held on 13 February 2025. The meeting will now be held on 14 February 2025.
Powered by Capital Market - Live News
-
-
HCG shares up as KKR set to steer the ship
36 days ago
The agreement, which involves a transaction with CVC, a global private markets manager, will see KKR acquire up to 54% of HCG’s equity from CVC Asia V at a price of Rs 445 per share.
In accordance with the Securities and Exchange Board of India (SEBI) Takeover Regulations, KKR will also conduct an open offer to purchase additional equity shares from public shareholders. Upon completion of the transaction, KKR's total equity stake in HCG is expected to range between 54% and 77%.
Dr. BS Ajaikumar, the founder of HCG, will transition to the role of non-executive chairman, where he will focus on driving clinical, academic, and research and development excellence within the organization.
The transaction is expected to close by the third quarter of 2025, subject to customary closing conditions and regulatory approvals.
Separately, KKR has initiated an open offer to acquire up to 26% of HCG’s expanded voting share capital, offering to purchase 3,70,90,327 equity shares at Rs 504.41 per share, for a total consideration of Rs 1870,87,31,842.07.
Founded in 1989, HCG is one of India’s largest oncology hospital chains. HCG operates 25 medical care centers across 19 cities with best-in-class infrastructure including 2,500 beds, nearly 100 operating theaters and 40 linear accelerator machines (LINACs).
Powered by Capital Market - Live News
-
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
46 days ago
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
14 - Feb - 2025 12:00 | 46 days ago
Net profit of Healthcare Global Enterprises rose 22.46% to Rs 6.98 crore in the quarter ended December 2024 as against Rs 5.70 crore during the previous quarter ended December 2023. Sales rose 18.89% to Rs 557.55 crore in the quarter ended December 2024 as against Rs 468.95 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 557.55 468.95 19 OPM % 15.85 16.76 - PBDT 53.22 55.22 -4 PBT -3.30 11.06 PL NP 6.98 5.70 22 Powered by Capital Market - Live News
-
Healthcare Global Enterprises has revised the meeting of the Board of Directors which was scheduled to be held on 13 February 2025. The meeting will now be held on 14 February 2025.
Powered by Capital Market - Live News
-
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
46 days ago
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
14 - Feb - 2025 12:00 | 46 days ago
Net profit of Healthcare Global Enterprises rose 22.46% to Rs 6.98 crore in the quarter ended December 2024 as against Rs 5.70 crore during the previous quarter ended December 2023. Sales rose 18.89% to Rs 557.55 crore in the quarter ended December 2024 as against Rs 468.95 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 557.55 468.95 19 OPM % 15.85 16.76 - PBDT 53.22 55.22 -4 PBT -3.30 11.06 PL NP 6.98 5.70 22 Powered by Capital Market - Live News
-
Healthcare Global Enterprises has revised the meeting of the Board of Directors which was scheduled to be held on 13 February 2025. The meeting will now be held on 14 February 2025.
Powered by Capital Market - Live News
-
Stock Trivia
Healthcare Global Enterprises Ltd is trading very close to its All time High
MF shareholding in Healthcare Global Enterprises Ltd has increased by 12.23% since past 3 Months
Healthcare Global Enterprises Ltd is trading very close to its All time High
Healthcare Global Enterprises Ltd is trading very close to its 52 Week High
FII shareholding in Healthcare Global Enterprises Ltd has decreased by -35.4% since past 3 Months
MF shareholding in Healthcare Global Enterprises Ltd has increased by 12.23% since past 3 Months
Healthcare Global Enterprises Ltd is trading very close to its All time High
MF shareholding in Healthcare Global Enterprises Ltd has increased by 12.23% since past 3 Months
